WS #15777
Holding: newest synthesis is 6d 2h old
Johnson & Johnson's Q3 profits were erased by a $5.5B talc charge, despite beating EPS estimates on an adjusted basis. In the consumer sector, Albertsons pulled its full-year guidance to focus on a turnaround plan, while LVMH's ongoing weakness confirms a lack of recovery in the luxury market.
Healthcare and Consumer Headwinds
Johnson & Johnson's Q3 profits were erased by a $5.5B talc charge, despite beating EPS estimates on an adjusted basis. In the consumer sector, Albertsons pulled its full-year guidance to focus on a turnaround plan, while LVMH's ongoing weakness confirms a lack of recovery in the luxury market.